[26] Patients were randomly assigned to receive a single daily dose of alvimopan 0.5 or 1 mg or placebo for 21 days. The average percentage of patients having at least one bowel movement within ...

2009;66(14):1267-1277. The second study group (n = 26) received placebo or increasing alvimopan doses (0.5, 1.5, 3, or 4.5 mg on days 1–4, respectively). Stool weight increased daily through day ...